Key points are not available for this paper at this time.
ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTContinuous Flow Synthesis. A Pharma PerspectiveLaia Malet-Sanz*† and Flavien Susanne‡View Author Information‡ †World-Wide Medicinal Chemistry and ‡Development API, Pfizer Global Research and Development, Ramsgate Road, Sandwich CT13 9NJ, U.K.*Phone: +44 (0) 1622 299 757. E-mail: email protectedCite this: J. Med. Chem. 2012, 55, 9, 4062–4098Publication Date (Web):January 27, 2012Publication History Received16 May 2011Published online27 February 2012Published inissue 10 May 2012https://pubs.acs.org/doi/10.1021/jm2006029https://doi.org/10.1021/jm2006029review-articleACS PublicationsCopyright © 2012 American Chemical SocietyRequest reuse permissionsArticle Views12372Altmetric-Citations337LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Catalysts,Chemical reactions,Fluid dynamics,Microreactors,Reagents Get e-Alerts
Malet‐Sanz et al. (Fri,) studied this question.